Literature DB >> 18781951

Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer.

Xing Cui1, Yayoi Kobayashi, Makoto Akashi, Ryuichi Okayasu.   

Abstract

Arsenic, a known human carcinogen, can induce tumors of the skin, urinary bladder, liver and lung etc.. On the other hand, arsenic is also a novel promising anticancer agent, and can be used effectively to treat acute promyelocytic leukemia (APL) and some other tumors. These paradoxical effects of arsenic not only result from direct or indirect influences on the genetic and epigenetic levels, but are also closely correlated with unique arsenic metabolism. This article reviews our recent studies as well as other reports on arsenic metabolism and epigenetic changes of DNA methylation during its metabolism. We also summarize the clinical use of arsenic trioxide (As2O3) to date and discuss new therapeutic strategies such as concurrent arsenic-radiation therapy to achieve local tumor control and enhance the radiosensitivity of solid tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781951     DOI: 10.2174/092986708785747526

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  17 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

Review 2.  Paradoxical and bidirectional drug effects.

Authors:  Silas W Smith; Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

3.  Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression.

Authors:  Chengzhi Chen; Xuejun Jiang; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Mol Mutagen       Date:  2014-10-23       Impact factor: 3.216

4.  Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.

Authors:  Clarisse S Muenyi; Allan R Pinhas; Teresa W Fan; Guy N Brock; C William Helm; J Christopher States
Journal:  Toxicol Sci       Date:  2012-02-13       Impact factor: 4.849

5.  Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production.

Authors:  ShiHai Zhang; Jing Zhou; CuiLing Zhang; HuiWen Wu; Yi Wang; JianMin Bian; Jun Guo; XiangYang Wu
Journal:  Med Oncol       Date:  2011-07-20       Impact factor: 3.064

6.  Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.

Authors:  Akira Ooki; Asma Begum; Luigi Marchionni; Christopher J VandenBussche; Shifeng Mao; Max Kates; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-02-14       Impact factor: 7.396

Review 7.  Chitin and chitosan as multipurpose natural polymers for groundwater arsenic removal and AS2O3 delivery in tumor therapy.

Authors:  Letizia Da Sacco; Andrea Masotti
Journal:  Mar Drugs       Date:  2010-04-28       Impact factor: 5.118

8.  Dose Response of MTLn3 Cells to Serial Dilutions of Arsenic Trioxide and Ionizing Radiation.

Authors:  Waseem Khan Raja; Jahangir Satti; Gang Liu; James Castracane
Journal:  Dose Response       Date:  2011-09-29       Impact factor: 2.658

9.  Oxidative damage in lymphocytes of copper smelter workers correlated to higher levels of excreted arsenic.

Authors:  Jorge Escobar; Lorena Varela-Nallar; Claudio Coddou; Pablo Nelson; Kevin Maisey; Daniel Valdés; Alexis Aspee; Victoria Espinosa; Carlos Rozas; Margarita Montoya; Cristian Mandiola; Felipe E Rodríguez; Claudio Acuña-Castillo; Alejandro Escobar; Ricardo Fernández; Hernán Diaz; Mario Sandoval; Mónica Imarai; Miguel Rios
Journal:  Mediators Inflamm       Date:  2010-12-28       Impact factor: 4.711

10.  Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension.

Authors:  Sebastian Schmeisser; Kathrin Schmeisser; Sandra Weimer; Marco Groth; Steffen Priebe; Eugen Fazius; Doreen Kuhlow; Denis Pick; Jürgen W Einax; Reinhard Guthke; Matthias Platzer; Kim Zarse; Michael Ristow
Journal:  Aging Cell       Date:  2013-05-06       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.